Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient-Derived Organoid Model in Breast Cancer
NCT03544047Unknown
- Sponsor
- Peking Union Medical College
- Start
- Jan 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of paclitaxel in breast cancer, sponsored by Peking Union Medical College. Primary endpoint: Overall Response rates at 36 months. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03544047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03544047.